Lior Sahaf brings diverse Business Development and Finance experience in big Pharma where he led, and worked with R&D, Commercial, Strategy, and Finance teams.
Before joining Clexio, Lior was a Business Development deal leader in the Roche-Genentech Partnering group where he evaluated, negotiated, and led diligence for licensing and acquisition deals across various therapeutic areas including Immunology and Personalized Healthcare. Prior to his role in Business Development, Lior held multiple finance roles in Genentech and Roche, working with teams across the product life cycle including R&D, Commercial, and group-level Finance teams.
Prior to Roche-Genentech, Lior was a commander in the Israeli Air Force where he served for 12 years.
Lior holds a B.A in Information Technology from the Ben Gurion University and an M.B.A from the University of Chicago Booth School of Business.
